Description
An orally bioavailable activator of Nurr1; selective for Nurr1 over Nur77, Nor1, and RXR; inhibits proliferation of Ku7 and 253J B-V bladder cancer cells in a dose-dependent manner at concentrations ranging from 2.5-10 µM; suppresses bladder cancer cell growth by 44 and 59% at doses of 12.5 and 25 mg/kg, respectively; neuroprotective in an MPTP mouse model of Parkinson’s disease; has analgesic and anti-inflammatory activity at a dose of 100 mg/kg in rats
Formal name: 3,3′-[(4-chlorophenyl)methylene]bis-1H-indole
Synonyms: 4-Chlorophenyl-3,3′-diindolylmethane
Molecular weight: 356.9
CAS: 178946-89-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Activators||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Transcription Factors||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease||Research Area|Neuroscience|Neuroprotection||Research Area|Neuroscience|Pain Research